Improved survival in adolescents and young adults (AYA) patients aged 14–55 years with acute lymphoblastic leukemia using pediatric-inspired protocol – a retrospective analysis of a real-world experience in 79 of patients treated at a national tertiary care referral center
暂无分享,去创建一个
M. Aljurf | A. Kotb | N. Chaudhri | W. Rasheed | S. Ahmed | Marwan Shaheen | A. Hanbali | F. Alsharif | H. Alzahrani | F. Almohareb | R. Fakih | Ahmad S. Alotaibi | F. Alfraih | S. Alhayli | Alfadel Alshaibani | Farah Deeba | A. Alahmari | M. A. Riash | Maryam Asif
[1] S. Chiaretti,et al. Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric‐like GIMEMA LAL‐1308 trial , 2020, American journal of hematology.
[2] T. Zhu,et al. [A pediatric-inspired regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: results from a single center]. , 2020, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.
[3] L. Muffly,et al. Pediatric-inspired protocols in adult acute lymphoblastic leukemia: are the results bearing fruit? , 2019, Hematology. American Society of Hematology. Education Program.
[4] M. Aljurf,et al. Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome. , 2019, Clinical lymphoma, myeloma & leukemia.
[5] C. Bloomfield,et al. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403. , 2019, Blood.
[6] Yun-Jing Huang,et al. Influence of pre-transplant minimal residual disease on prognosis after Allo-SCT for patients with acute lymphoblastic leukemia: systematic review and meta-analysis , 2018, BMC Cancer.
[7] A. Bleyer,et al. Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: A Review , 2018, JAMA oncology.
[8] Susan M Sawyer,et al. The age of adolescence. , 2018, The Lancet. Child & adolescent health.
[9] D. Wechsler,et al. Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.
[10] Olaf Klungel,et al. What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[11] W. Stock,et al. How I treat acute lymphoblastic leukemia in older adolescents and young adults. , 2015, Blood.
[12] B. Leber,et al. Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia , 2014, Leukemia.
[13] M. Loh,et al. T-Lymphoblastic Leukemia (T-ALL) Shows Excellent Outcome, Lack of Significance of the Early Thymic Precursor (ETP) Immunophenotype, and Validation of the Prognostic Value of End-Induction Minimal Residual Disease (MRD) in Children’s Oncology Group (COG) Study AALL0434 , 2014 .
[14] Mel Greaves,et al. Acute lymphoblastic leukaemia , 2013, The Lancet.
[15] C. Pui,et al. Glucocorticoid use in acute lymphoblastic leukemia: comparison of prednisone and dexamethasone , 2012 .
[16] D. Hoelzer,et al. Modern therapy of acute lymphoblastic leukemia. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] C. Pui,et al. Glucocorticoid use in acute lymphoblastic leukaemia. , 2010, The Lancet. Oncology.
[18] M. Minden,et al. Treatment of adults with BCR‐ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen , 2009, British journal of haematology.
[19] Cheng Cheng,et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. , 2009, The New England journal of medicine.
[20] H. Dombret,et al. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] C. Bloomfield,et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. , 2008, Blood.
[22] E. Mantadakis,et al. High‐Dose Methotrexate in Acute Lymphoblastic Leukemia: Where Is the Evidence for Its Continued Use? , 2005, Pharmacotherapy.
[23] M. Campbell,et al. High‐dose methotrexate therapy of childhood acute lymphoblastic leukemia: Lack of relation between serum methotrexate concentration and creatinine clearance , 2004, Pediatric blood & cancer.
[24] J. Cayuela,et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] J. Neglia,et al. A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. , 2002, Blood.